Last reviewed · How we verify

Omega-3-acid ethyl esters 90 — Competitive Intelligence Brief

Omega-3-acid ethyl esters 90 (Omega-3-acid ethyl esters 90) competitive landscape: 0 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Fibrate-like lipid-lowering agent / Omega-3 fatty acid. Area: Cardiovascular.

marketed Fibrate-like lipid-lowering agent / Omega-3 fatty acid Cardiovascular Small molecule Live · refreshed every 30 min

Target snapshot

Omega-3-acid ethyl esters 90 (Omega-3-acid ethyl esters 90) — Pronova BioPharma. Omega-3-acid ethyl esters reduce triglyceride levels by decreasing hepatic production of triglyceride-rich lipoproteins and increasing clearance of triglycerides from the bloodstream.

Comparator set

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

DrugGenericSponsorPhaseClassTargetApproval / PDUFA
Omega-3-acid ethyl esters 90 TARGET Omega-3-acid ethyl esters 90 Pronova BioPharma marketed Fibrate-like lipid-lowering agent / Omega-3 fatty acid

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Fibrate-like lipid-lowering agent / Omega-3 fatty acid class)

  1. Pronova BioPharma · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Omega-3-acid ethyl esters 90 — Competitive Intelligence Brief. https://druglandscape.com/ci/omega-3-acid-ethyl-esters-90. Accessed 2026-05-18.

Build your own brief

Pick any drug + add comparators: